CHROMagar

Pre-clinical

Paris, FranceFounded 1993chromagar.com

CHROMagar is a leader in chromogenic culture media, founded on the pioneering 1979 invention of Dr. Alain Rambach. The company's core technology enables rapid, color-based phenotypic detection of microorganisms, simplifying laboratory workflows and reducing costs. With ISO 13485 certification, a global distributor network, and a portfolio covering clinical, veterinary, food, and water testing, CHROMagar provides critical diagnostic solutions for infection control and quality assurance worldwide.

Founded

1993

AI Company Overview

Technology Platform

Proprietary chromogenic culture media technology that uses enzyme-specific substrates linked to chromophores to produce colored colonies, enabling rapid visual identification and differentiation of microorganisms.

Opportunities

Growth is driven by the persistent global need for rapid pathogen detection in healthcare (combating antimicrobial resistance), food safety, and water quality control.

Expanding its product range for emerging pathogens and leveraging Kanto Chemical's Asian distribution network present significant opportunities.

Risk Factors

Key risks include competition from larger diagnostic companies and disruptive molecular technologies, potential commoditization of basic media, regulatory hurdles for new products, and strategic dependence on its parent company, Kanto Chemical.

Competitive Landscape

CHROMagar competes with large diversified players like BioMérieux, BD, and Thermo Fisher, as well as other chromogenic media specialists. Its differentiation lies in its pioneering heritage, deep specialization, broad dehydrated media portfolio, strong R&D focus, and extensive global distributor network.